COPD and Metabolic Syndrome: Unanswered Questions and Opportunities for Innovation

Overview

Journal Chronic Obstr Pulm Dis

Date 2024 Nov 22

PMID 39576959

Authors

Jamuna K Krishnan

Jessica Bon

Affiliations

Soon will be listed here.

References

Krishnan J, Rajan M, Banerjee S, Mallya S, Han M, Mannino D . Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2022; 19(10):1661-1668. PMC: 9528745. DOI: 10.1513/AnnalsATS.202112-1346OC. View

Hirode G, Wong R . Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. JAMA. 2020; 323(24):2526-2528. PMC: 7312413. DOI: 10.1001/jama.2020.4501. View

Marquis K, Maltais F, Duguay V, Bezeau A, LeBlanc P, Jobin J . The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005; 25(4):226-32. DOI: 10.1097/00008483-200507000-00010. View

Chlif M, Keochkerian D, Feki Y, Vaidie A, Choquet D, Ahmaidi S . Inspiratory muscle activity during incremental exercise in obese men. Int J Obes (Lond). 2007; 31(9):1456-63. DOI: 10.1038/sj.ijo.0803546. View

Krein S, Hofer T, Holleman R, Piette J, Klamerus M, Kerr E . More than a pain in the neck: how discussing chronic pain affects hypertension medication intensification. J Gen Intern Med. 2009; 24(8):911-6. PMC: 2710469. DOI: 10.1007/s11606-009-1020-y. View

Galassi A, Reynolds K, He J . Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006; 119(10):812-9. DOI: 10.1016/j.amjmed.2006.02.031. View

Wei Y, Tsai Y, Wang C, Kuo P . Impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan Obstructive Lung Disease cohort. Int J Chron Obstruct Pulmon Dis. 2017; 12:2723-2729. PMC: 5602448. DOI: 10.2147/COPD.S138571. View

Grace J, Leader J, Nouraie S, Pu J, Chandra D, Zhang Y . Mediastinal and Subcutaneous Chest Fat Are Differentially Associated with Emphysema Progression and Clinical Outcomes in Smokers. Respiration. 2017; 94(6):501-509. DOI: 10.1159/000479886. View

Zou R, Nouraie S, Karoleski C, Zhang Y, Sciurba F, Forman D . Incident low muscle mass is associated with greater lung disease and lower circulating leptin in a tobacco-exposed longitudinal cohort. Respir Res. 2023; 24(1):224. PMC: 10515430. DOI: 10.1186/s12931-023-02521-3. View

10.

Kroenke K, Unutzer J . Closing the False Divide: Sustainable Approaches to Integrating Mental Health Services into Primary Care. J Gen Intern Med. 2017; 32(4):404-410. PMC: 5377893. DOI: 10.1007/s11606-016-3967-9. View

11.

Mannino D, Thorn D, Swensen A, Holguin F . Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32(4):962-9. DOI: 10.1183/09031936.00012408. View

12.

Zhu T, Wu X, Zhang W, Xiao M . Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice. Int J Mol Sci. 2015; 16(9):20195-211. PMC: 4613197. DOI: 10.3390/ijms160920195. View

13.

Au D, Gleason E, Hunter-Merrill R, Baron A, Collins M, Ronneberg C . Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical Trial. Ann Am Thorac Soc. 2023; 20(12):1743-1751. PMC: 10704228. DOI: 10.1513/AnnalsATS.202305-458OC. View

14.

Safford M, Andreae S, Cherrington A, Martin M, Halanych J, Lewis M . Peer Coaches to Improve Diabetes Outcomes in Rural Alabama: A Cluster Randomized Trial. Ann Fam Med. 2015; 13 Suppl 1:S18-26. PMC: 4648138. DOI: 10.1370/afm.1798. View

15.

Vanfleteren L, Spruit M, Groenen M, Gaffron S, van Empel V, Bruijnzeel P . Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 187(7):728-35. DOI: 10.1164/rccm.201209-1665OC. View

16.

Fabbri L, Celli B, Agusti A, Criner G, Dransfield M, Divo M . COPD and multimorbidity: recognising and addressing a syndemic occurrence. Lancet Respir Med. 2023; 11(11):1020-1034. DOI: 10.1016/S2213-2600(23)00261-8. View

17.

Poot C, Meijer E, Kruis A, Smidt N, Chavannes N, Honkoop P . Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021; 9:CD009437. PMC: 8425271. DOI: 10.1002/14651858.CD009437.pub3. View

18.

Agusti A, Edwards L, Rennard S, MacNee W, Tal-Singer R, Miller B . Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012; 7(5):e37483. PMC: 3356313. DOI: 10.1371/journal.pone.0037483. View

19.

Goto T, Hirayama A, Faridi M, Camargo Jr C, Hasegawa K . Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2017; 15(2):184-191. DOI: 10.1513/AnnalsATS.201706-485OC. View

20.

Rennard S, Locantore N, Delafont B, Tal-Singer R, Silverman E, Vestbo J . Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc. 2015; 12(3):303-12. DOI: 10.1513/AnnalsATS.201403-125OC. View